drugset / Trial / NCT05468645
In Vivo Mass Balance Study of [14C]Hemay005
NaSingle-groupOpen-labelOther
Summary
This study is a single-center, single-dose, non-randomized, open-label study to evaluate the in vivo mass balance of \[14C\]Hemay005. Six healthy male subjects are planned to be enrolled.
Timeline
- Start
- 2022-07-25
- Primary completion
- 2022-09-01
- Completion
- 2022-09-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | MUFEMILAST | Small molecule | 60 mg | Oral |
Indications
No indication recorded.